We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

New Approach to the Management of the Suicidal Patient

By HospiMedica International staff writers
Posted on 24 Dec 2014
A new study suggests that an adjunctive acceptance and commitment therapy (ACT) group program could be effective in treating suicidal behaviors.

Researchers at Academic Hospital of Montpellier (France) and Lapeyronie Hospital (Montpellier, France) conducted a study involving 35 outpatients suffering from a current suicidal behavior disorder (SBD), which is defined (according to DSM-5) as a history of suicidal attempt in the past year. The patients were included in an ACT program, and were assessed at inclusion, after one week, and three months after program completion. Exclusion criteria were current mania or depressive episodes, or schizophrenia.

The results showed that between inclusion and the one week follow-up, there was a significant reduction in the intensity of suicidal ideations during the last 15 days. There was also a significant reduction in depression symptoms, anxiety state, hopelessness, and psychological pain, and a significant improvement in global functioning and quality of life. All the differences remained significant at three month follow up, and dosages of benzodiazepines were reduced for 65% of the patients. Notably, there was no suicide reattempt during the follow-up period. The study was published on December 9, 2014, in the Journal of Psychotherapy and Psychosomatics.

“ACT, a ‘third-wave' behavioral therapy, specifically focuses on experiential avoidance, that is the tendency to avoid unwanted thoughts or emotions, at the core of psychiatric disorders,” concluded lead author Deborah Ducasse, MD, of the department of psychiatric emergency and acute crisis at Lapeyronie Hospital. “This may be a key aspect in suicidal subjects who often report intrusive mental images of suicide that they try to suppress, increasing in their intensity and frequency, independently from depressive symptoms.”

ACT is a is an empirically based psychological intervention that uses acceptance and mindfulness strategies mixed in different ways with commitment and behavior-change strategies to increase psychological flexibility. Rather than trying to teach people to better control their thoughts, feelings, sensations, and memories as in traditional cognitive behavioral therapy (CBT), ACT teaches them to observe, accept, and embrace their private events, especially previously unwanted ones. The method was developed in the late 1980s.

Related Links:

Academic Hospital of Montpellier
Lapeyronie Hospital


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Instrument Cabinet
TRZY-068
New
Electrically Operated Patient Lifter
SVL 205

Channels

Surgical Techniques

view channel
Image: The proposed hyperspectral endoscopic imaging system includes a spectral LED array in the catheter tip (Courtesy of N. Modir et al., doi 10.1117/1.JMI.12.3.035002)

LED-Based Imaging System Could Transform Cancer Detection in Endoscopy

Gastrointestinal cancers remain one of the most common and challenging forms of cancer to diagnose accurately. Despite the widespread use of endoscopy for screening and diagnosis, the procedure still misses... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more